Annual Report

Donor Support for Contraceptives and Condoms for STI/HIV Prevention 2010

Number of pages: 30

Publication date: 01 Jan 2011

Author: UNFPA

Publisher: UNFPA

EN

This report, updated annually, is a rich source of data for development that can drive good planning for contraceptive supply, advocacy and resource mobilization. The report contains dozens of figures, tables and graphs, and is full of information and analysis that can influence policy dialogue, advocacy and interagency work. It aims to enhance coordination among donors, improve partnerships between donors and national governments, and mobilize the resources needed to accelerate progress towards universal access to sexual and reproductive health, as set forth in the ICPD Programme of Action and the Millennium Development Goals.

Highlights of this year's report:

  • Donors provided $235.16 million in 2010, a slight decrease of 1.5 per cent from $238.8 million in 2009.
  • Bilateral funding accounted for 51.7 per cent of total donor support in 2010. Another 34.7 per cent was channeled through UNFPA and 12.9 per cent through social marketing organizations.
  • Of total donor support in 2010, sub-Saharan Africa received 63 per cent, Asia and the Pacific region received 25 per cent, Latin America and the Caribbean received 7 per cent and the Arab States received 4 per cent.
  • Sub-Saharan Africa received $25.4 million less than in the previous year, down from $173.1 million in 2009 to $147.6 million in 2010.
  • More than 77 per cent of donor support in 2010 was allocated to three types of commodities: male condoms (32 per cent), injectables (24 per cent) and oral contraceptives (21 per cent).
  • Donors provided less support in 2010 than in 2009 for three contraceptives methods, with a decrease of 51 per cent for female condoms, 31 per cent for emergency contraceptives, and 17.5 per cent for implants.
  • As in previous years, the highest expenditure in 2010 was on condoms. Expenditure on both male and female condoms together was 37 per cent of total donor support; followed by 24 per cent on injectables and 22 per cent on oral contraceptives (combined oral pills and emergency contraceptive pills).

Previous Editions:

We use cookies and other identifiers to help improve your online experience. By using our website you agree to this, see our cookie policy

X